|
Volumn 44, Issue 1, 2000, Pages 235-249
|
Drug-like properties and the causes of poor solubility and poor permeability
a |
Author keywords
Absorption; ADME; Chemical diversity; Clinical candidate; Drug like; Merck; Permeability; Pfizer; Solubility
|
Indexed keywords
(2 CYCLOPENTYL 6,7 DICHLORO 2 METHYL 1 OXO 5 INDANYLOXY)ACETIC ACID;
2 AMINOMETHYL 4 TERT BUTYL 6 IODOPHENOL;
3A,4,5,6,7,7A HEXAHYDRO 3 (1 METHYL 5 NITRO 1H IMIDAZOL 2 YL) 1,2 BENZISOXAZOLE;
5 (N,N DIMETHYL)AMILORIDE;
6 CHLORO 2 (1 PIPERAZINYL)PYRAZINE;
ABAMECTIN;
ALLOCLAMIDE;
AMILORIDE;
AMITRIPTYLINE;
ARPRINOCID;
CARBIDOPA;
CEFOXITIN;
CLORSULON;
CYCLOBENZAPRINE;
DEXAMETHASONE;
DIFLUNISAL;
DIZOCILPINE;
ENALAPRILAT;
ETACRYNIC ACID;
FOSFOMYCIN;
IMIPENEM;
LISINOPRIL;
METHYLDOPA;
MEVINOLIN;
PROTRIPTYLINE;
RAFOXANIDE;
TIABENDAZOLE;
TIMOLOL MALEATE;
UNINDEXED DRUG;
ZERANOL;
ARTICLE;
COMBINATORIAL CHEMISTRY;
DRUG ABSORPTION;
DRUG DESIGN;
DRUG DISTRIBUTION;
DRUG EXCRETION;
DRUG METABOLISM;
DRUG PENETRATION;
DRUG RESEARCH;
DRUG SCREENING;
DRUG SOLUBILITY;
HYDROGEN BOND;
LIPOPHILICITY;
MOLECULAR WEIGHT;
DRUG INDUSTRY;
HUMANS;
HYDROGEN BONDING;
MOLECULAR WEIGHT;
PERMEABILITY;
PHARMACOKINETICS;
SOLUBILITY;
|
EID: 0034461768
PISSN: 10568719
EISSN: None
Source Type: Journal
DOI: 10.1016/S1056-8719(00)00107-6 Document Type: Article |
Times cited : (3098)
|
References (18)
|